| DB ID | MyCo_5370 |
| Title | Kinetics and Role of Pancreatic Stone Protein and Midregional Proadrenomedullin as Predictors of Sepsis and Bacteremia in Children with Hematological Malignancies |
| Year | 2023 |
| PMID | 38028393 |
| Fungal Diseases involved | Fungal sepsis |
| Associated Medical Condition | Hematological Malignancies |
| Genus | Candida |
| Species | spp. |
| Organism | Candida spp. |
| Ethical Statement | The studyprotocol was approved by the Ethics Committee of the Medical School of Aristotle University of Thessaloniki, Greece (42/2022). |
| Site of Infection | None |
| Opportunistic invasive | None |
| Sample type | Body fluid |
| Sample source | Plasma |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | PSP |
| Biomarker Full Name | Pancreatic stone protein |
| Biomarker Type | Prognostic |
| Biomolecule | Protein |
| Geographical Location | Greece |
| Cohort | At the Pediatric Hematology- Oncology Unit of the 2nd Pediatric Department of the Aristotle University of Thessaloniki, Greece, 70 febrile neutropenic consecutive episodes in 70 children with hematological malignancies were collected and analyzed prospectively from January 2020 to December 2022. |
| Cohort No. | 70 |
| Age Group | Jan-18 |
| P Value | None |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | Immunological assay |
| Analysis Method | Nanofluidic immunoassay |
| ELISA kits | CE-marked IVD PSP capsule on the abioSCOPE® platform (Abionic SA, Epalinges, Switzerland). , sandwich immunoassay Kit (Novus Biologicals, USA). |
| Assay Data | None |
| Validation Techniques used | Nanofluidic immunoassay |
| Up Regulation Down Regulation | Positive |
| Sequence Data | None |
| External Link | None |
